Kyverna Therapeutics: Immune Reset Is Clinically Validated, Market Ignores Potential

Kyverna Therapeutics (KYTX) is rated a strong buy with promising KYV-101 Phase 2 data and near-term catalysts. Read here for ...
eLife

Apparent cooperativity between human CMV virions introduces errors in conventional methods of calculating multiplicity of infection

Whether infection of cells by individual virions occurs randomly or if there is some form (s) of competition or cooperativity between individual virions remains largely unknown for most virus-cell ...
Goldseiten

EcoGraf Limited: Epanko Expansion Supports EcoGraf HFfree® Downstream Facilities

EcoGraf is pleased to announce the Epanko Graphite Project Expansion Study examined the potential to expand production to support the Company's strategy of developing its commercial scale EcoGraf ...